July 21, 2015
Dr Nishio (right), Dr Rizvi Speak at JSMO Meeting in Sapporo Japanese and US oncologists traded barbs over the financial impact of the anti-PD-1 antibody Opdivo (nivolumab) at an annual meeting of the Japanese Society of Medical Oncology in Sapporo...read more